November 25, 2025

FDA OKs First SMA Gene Replacement Therapy

The FDA approved Itvisma, the first gene replacement therapy for children 2 years and older, teens, and adults with spinal muscular atrophy, a one-time treatment that replaces the SMN1 gene and demonstrated improved motor function in Phase 3 studies.

Conexiant

November 24, 2025

Why Youth E-Bike Injuries Are Increasing

Rising youth e-bike use and injuries amid limited federal oversight and evolving state safety rules.

KFF Health News

November 21, 2025

EULAR: Issues With the RA Definition?

Researchers examine the strengths and shortcomings of the current European Alliance of Associations for Rheumatology definition for difficult-to-treat rheumatoid arthritis.

Conexiant

November 17, 2025

Active PsA Linked to Maternal Hypertension in Pregnancy

Researchers explore links between psoriatic arthritis and maternal health.

Conexiant

November 13, 2025

Why Is the US an ‘Outlier’ in Road Safety?

US traffic fatalities have increased over the past decade despite ongoing safety initiatives.

KFF Health News

November 13, 2025

‘FDA Said Yes, Despite Inconclusive Evidence’

The FDA’s authorization of the Q-Collar is under scrutiny after researchers identified duplicated data, altered study endpoints, and unsubstantiated “brain protection” claims.

Conexiant

November 12, 2025

Radiation Training Levels May Influence Safety Culture

Researchers examine how radiation knowledge shapes health care safety attitudes.

Conexiant

November 10, 2025

Which Dressing Best Supports Scar Healing?

Researchers compare Dermabond and Steri-Strips performance after breast surgery.

Conexiant

November 06, 2025

New MRI Model Sharpens Osteosarcoma Risk Prediction

Its predictive accuracy was consistent independently from chemotherapy effects.

Conexiant